Parasites and other infections have many effects on the gastrointestinal tract of individuals who are immunocompromised. Few reviews focus on parasitic infections, which are covered here.
Introduction
Gastrointestinal infections are more common and more severe in immunocompromised individuals and may affect the whole gastrointestinal tract, from viral and fungal infections of the oropharynx to viral and bacterial infections of the distal colon and anus [1] . Recent reviews have concentrated on specific pathogens [2] , and on the aetiology and management of diarrhoea in HIV-infected adults [3, 4] or children [5] . In this review, we focus on publications over the past year on protozoal causes of diarrhoea in the immunocompromised, then discuss the emerging literature on the complex interactions between HIV and helminth and trematode infections, before finishing with the novel concept of using helminth therapy for Crohn's disease.
General points
The causes of diarrhoea in the immunosuppressed are often multifactorial and include antitretroviral drugs, immunomodulators such as mycophenolate, alcohol and other noninfectious causes, as well as the effects of systemic infections such as tuberculosis. After intestinal transplantation, 39% of patients have significant infectious enteritis, and viral infections are more common and more serious than infections with parasites [6] . In advanced HIV, multiple pathogens may be involved and comorbidity of Cryptosporidium spp., cytomegalovirus and Mycobacterium avium complex (MAC) infections is well recognized. Parasites are more likely to be the cause of HIV-related diarrhoea in those with prolonged symptoms, weight loss, low CD4 lymphocyte counts (<100 Â 10 6 /l) and those not taking highly active antiretroviral therapy (HAART). Conversely, using HAART to raise the CD4 count of patients with chronic diarrhoea by more than 50 Â 10 6 /l results in resolution of diarrhoea in more than 85% of affected individuals [4] . As a result, the incidence of parasite-related diarrhoea in HIVpositive individuals has fallen dramatically in the last decade in countries where HAART has been widely introduced. It remains a major problem, however, for the majority of the world's HIV-positive individuals, who live in resource-poor settings without access to HAART.
Studies on the aetiology of HIV-related diarrhoea are difficult to perform, particularly in the tropics. Large numbers of patients and controls are required to provide adequate statistical power to confirm disease associations of parasites which may only be present in 10-20% of cases and which are also found in the general population. Ideally, HIV-positive and negative controls, with and without diarrhoea, should be included. Even the definitions of diarrhoea, particularly chronicity, vary from study to study. Most published studies fail to perform adequate concurrent investigations for viruses, bacteria, protozoa and other parasites, and systemic infections that also affect the bowel may be omitted, particularly cytomegalovirus and MAC. The quality of investigations may be inadequate; for example, specific culture techniques to detect Strongyloides spp. are rarely performed [7] , and the diagnosis of microsporidial infections remains a technical challenge for most laboratories [8 ] . Nevertheless, such studies are important, particularly as novel therapies become available [9 ,10 ].
Specific methods for the diagnosis of each of several protozoal infections are time-consuming, and molecular methods are increasingly being used in laboratories that have appropriate resources and where labour costs make multiple species-specific methods of stool examination more expensive. A multiplex real-time polymerase chain reaction (PCR) assay has been developed for the simultaneous detection of Entamoeba histolytica, Giardia lamblia, and Cryptosporidium parvum in stool samples. The test was 100% specific and sensitive when performed on a small number of species-specific DNA controls and well defined stool samples [11 ] . This principle is likely to be extended to include other parasites in developed countries and will be particularly useful for laboratories that have little expertise and experience of more traditional parasitological practice. It will be a limited option, however, for resource-poor countries, which have the greatest burden of disease.
Burden of intestinal parasites and HIV
Several relevant studies in the past year have compared intestinal parasite infections in HIV-negative and positive individuals. The most prevalent parasite varied from country to country, as did the prevalence of infection in HIV-positive and negative individuals, but HIV-positive patients always had the highest burden of disease. In Brazil, 27% of 100 HIV patients had intestinal parasitic infections compared with 17% of healthy individuals [12] . In urban Peru, parasitic infections were found in 47% of 147 HIV-positive patients with diarrhoea for more than 7 days compared with 16% of HIV-positive, diarrhoeafree, unmatched controls [13] . Similarly, in Ethiopia a high proportion of patients with HIV-related symptoms had parasite infections (52%) compared with 42% of HIVnegative controls [14] . In this study only direct faecal smears and formol-ether concentrated samples were examined and helminths were more common than protozoa in both patient groups. The only significantly different parasite prevalence was for Blastocystis hominis (14.1% HIV versus 0% controls), the clinical significance of which remains controversial [15 ] . In Peru, Cryptosporidium spp. were the most common and significant parasites (20% versus 7%). In the Brazilian series, Strongyloides stercoralis was the most common parasite (12% versus 7% controls; p not significant) and other helminths were equally prevalent in both groups, but only the HIVpositive patients had infections with Isospora belli and Cryptosporidium spp. In an uncontrolled series of 133 HIV-positive outpatients without AIDS-defining symptoms in Honduras, 67% were infected with parasites but only 11% had diarrhoea. In this study, there was a strong correlation between the presence of geohelminth infection and peripheral blood eosinophilia, but not with CD4 cell count [16] .
Established protozoal pathogens
Several protozoal pathogens are well established causes of diarrhoea in the immunocompromised.
Cryptosporidiosis
Cryptosporidium spp. are still significant causes of mortality and morbidity throughout the world. Infections are usually linked to contaminated water and there have been numerous outbreaks of cryptosporidiosis, including infection from swimming pools [17] and lake water [18] . Young children are known to be particularly susceptible [18] and the long recognized association with malnutrition and poor outcome (including death), even without HIV comorbidity, was confirmed in a recent case control study in Accra, Ghana [19] . In this setting, breast-feeding for the first 6 months of life was protective against infection, suggesting the importance of transferable antibodymediated immunity.
Cryptosporidiosis is a particular problem in HIV-positive and other immunocompromised adults [20 ] . A recent study showed that up to 20% of Indian renal transplant patients may be infected, although many are asymptomatic [21] . Improvements in molecular diagnostic techniques reveal that a number of species infect man, and that we have much to learn about the pathophysiology and response to therapy of these different species [22 ] . Anthropozoonotic C. parvum and nonzoonotic C. hominis are the main species causing infection in humans, although other zoonotic species such as C. canis, C. felis, C. meleagridis and C. muris have been found in HIVpositive patients [23] . Sequential infection with different species has been reported in a patient following ileal transplantation, and the distinction between species could not have been diagnosed with conventional microscopy [24] .
Biliary disease occurs in 10-15% of HIV-positive patients with cryptosporidiosis, with severe attendant morbidity in those with low CD4 counts [25] . This may be difficult to diagnose, and a recent Brazilian patient presented with symptoms mimicking carcinoma of the head of the pancreas [26] . A case report from New Zealand suggests a link between infection and reactive arthritis, something that had only previously been seen in children or in HIVpositive adults [27] .
Treatment of cryptosporidiosis is difficult because of the intracellular location of the parasite in enterocytes [28] ( Fig. 1 ), and its innate resistance to many agents [22 ] . Although paramomycin, with or without azithromycin, had become accepted for symptom control a decade ago, this combination is expensive and paromomycin alone was later shown to be no more effective than placebo in HIV-infected patients [29] . Nitazoxanide has shown promise, hastening the clearance of parasites and improving the clinical outcome of 56% of malnourished HIVnegative Zambian children, while repeated courses of therapy were required before diarrhoea improved in the HIV-positive group [30] . The role of nitazoxanide in treatment of cryptosporidiosis in the severely immunosuppressed remains uncertain, although it has been used to treat a wide range of parasites [9 ,10 ].
HAART has reduced the incidence of cryptosporidial diarrhoea in HIV-infected individuals, largely due to its effect on boosting the immune system and raising the CD4 cell count. Earlier work suggests that protease inhibitors may also have a direct effect on cryptosporidia. Using indinavir, an aspartyl protease inhibitor, a reduction was seen in infected cells in vitro from 90% to 38% and there was a 70% reduction in intestinal oocysts in animal models. Several different C. parvum sequences were shown to have homology with a protein family related to aspartyl proteases. Protease inhibitors may be useful agents in the treatment of cryptosporidiosis [31, 32] . In-vitro work has shown a similar inhibitory effect of nelfinavir and ritonavir on infection and development of cryptosporidia in cell lines, and these effects were further increased when used in combination with paromomycin [33] .
Given that these drug options are not ideal, new potential drug targets must be explored. Cryptosporidia were formerly thought to be related to the apicomplexa, but do not respond to drugs such as macrolides that are active against this group of organisms. Comparisons between genetic databases suggest a lack of an acipoplast, which may explain this. Cryptosporidia also lack identifiable genes for de-novo synthesis of pyrimidine, amongst others, and appear to be more related to gregarines [22 ] . Identification of new molecular targets and the recent ability to produce cell-free cultures of C. parvum may aid further drug development [34] .
Cyclosporiasis
Cyclospora cayetanensis, a food and waterborne coccidian protozoan parasite, is of increasing importance as a pathogen. A total of 3600 people were affected by 11 foodborne outbreaks of cyclosporosis between 1999 and 2000 in North America [35 ] . Foodborne outbreaks are typically associated with fruits such as raspberries, blackberries and blueberries and more recently with imported Thai basil [36 ] . Cyclosporiasis is particularly recognized as a seasonal cause of diarrhoea in travellers to Nepal and Central and South America, but is underdiagnosed because most laboratories fail to recognize it in direct faecal smear examinations ( Fig. 2 ). Special stains such as modified acid fast stain, auramine-phenol or modified trichrome are usually required [37] . Highly sensitive PCR methods have been devised for use in the food industry, but these have not yet been introduced into routine use for diagnosis of human infections. Infection usually responds to a 7-day course of trimethoprimsulfamethoxazole (TMP-SMX). Diarrhoea is not necessarily more severe in people who are immunosuppressed due to HIV or other conditions such as leukaemias or cirrhosis [38] , but has a high recurrence rate, which may be prevented by TMP-SMX [39] . Nitazoxanide is said to be an effective alternative.
Isosporiasis
The natural reservoir for Isospora belli, an exclusively human pathogen, remains unknown ( Fig. 3 ). Recent reports confirm its worldwide distribution as a cause of diarrhoea in HIV-positive individuals [12, 37, 40, 41] . 
Microsporidiosis
Microsporidia are single-celled, obligate intracellular parasites that have recently been reclassified from protozoa to fungi, but will nevertheless be considered in this section. Probably underestimated as causes of traveller's diarrhoea, they are currently considered mainly in the context of diarrhoea in the immunocompromised, particularly in association with HIV. As with other parasites such as cryptosporidium, there are occasional reports of 'intestinal' species being found in association with pulmonary disease in patients with HIV [42] and after bone marrow transplantation [43] . Other species and genera are well recognized causes of upper and lower respiratory and eye infections [8 ] .
Diagnosis in routine laboratory practice is difficult because of the size of the organisms (similar to bacteria) in faeces, and the nonspecificity of special stains such as calcofluor that stain chitin in spore walls, but which also stain yeasts etc. The recent successful development of species-specific antibodies that react with spores of Enterocytozoon bieneusi may be useful in diagnosis of cases in the field [44] . E. bieneusi (Fig. 4) is responsible for most cases of microsporidial diarrhoea in association with HIV [8 ] . Spore excretion varies from day to day and may be missed by light microscopy of faeces, but more sensitive species-specific PCR methods are increasingly being used in research studies and should prove to be useful in future routine diagnostic practice [45] [46] [47] . Previous technical problems with extraction from stools and PCR inhibitors in faeces have been overcome using FTA filters, although several PCR targets have been described with differing sensitivities [48] . As diagnostic techniques improve, the true prevalence of microsporidiosis in both immunosuppressed and immunocompetent individuals will need to be reassessed. Carriage and infections are probably more widespread in both symptomatic and asymptomatic individuals than previously thought, especially in children [49] . Similarly, the role of differing genotypes and the extent of zoonotic infections have barely been explored. Treatment remains a challenge: albendazole is effective against E. intestinalis in the bowel and other Encephalitozoon spp. that affect eyes and sinuses, but not against E. bieneusi in the immunocompromised. Fumagillin has broader antimicrosporidial activity [50] , but is toxic in mammals, suggesting a need to identify better drugs [51 ] . In HIV-positive patients, improvement of immune status with HAART usually leads to reduction or cessation of microsporidial diarrhoea. Patients who cannot tolerate HAART sometimes respond to nonspecific therapy such as thalidomide, although the availability and suitability of such therapy is limited [52] . Other intestinal chemokine or tumour necrosis factor inhibitors may prove to be more acceptable as nonspecific therapeutic agents.
Possible new parasitic associations with immunosuppression
Two new associations have been reported in the last year.
Amoebiasis
Although Entamoeba histolytica and E. dispar are more common in homosexual men, few studies have shown any associations with HIV apart from reports from Taiwan and neighbouring areas. A recent prospective controlled study in Taiwan suggests that invasive amoebiasis is both more common and more severe in HIV-positive patients, in whom it may be the first indicator of immunosuppression [53 ] .
Myxozoa
Myxozoan parasites usually affect fish and other invertebrates, causing diseases such as whirling disease of salmon and trout. There have been a few reports of myxozoan organisms such as Myxobolus spp. in the faeces of patients with diarrhoea and HIV [54] . An illustrated report from Egypt describes three cancer chemotherapy patients with diarrhoea and Myxobolus spp. in their stools [55] . In each patient another parasite was also found such as C. parvum, Giardia lamblia or Hymenolepis nana, so the role of Myxobolus spp. as a pathogen remains uncertain.
Trematodes and cestodes
Until recently, little has been published about the effects of reduced immunity on host response to worms and flukes, but this is changing.
Alveolar hydatid disease
Previous case reports have suggested rapid progression of alveolar echinococcosis due to Echinococcus multilocularis in the immunocompromised. A recent report from Zurich describes an HIV-positive patient with a CD4 cell count between 27 and 150 Â 10 6 /l while taking protease inhibitors. The patient was relatively asymptomatic from his alveolar echinococcosis and required only 10% of standard doses of mebendazole to maintain therapeutic levels. The authors speculated that there is a critical level of immunosuppression that is effective in controlling alveolar echinococcosis in HIV-positive individuals. The elevated benzimidazole levels were ascribed to a presumed interaction with protease inhibitors, which are potent inhibitors of cytochrome P450 (CYP3A4) [56] .
Schistosomiasis
In Kenya, HIV-positive patients with low CD4 counts excreted fewer schistosome eggs than HIV-negative controls despite having equivalent adult worm loads, and HIV-positive individuals were more susceptible to reinfection with schistosomiasis than were HIV-negative individuals. HIV-negative controls with hepatic fibrosis due to schistosomiasis also had lower CD4 cell counts than normal [57 ] . The authors suggest that this may lead to more rapid progression of HIV infection should a previously HIV-negative individual with schistosomiasis become infected with HIV. After treatment with praziquantel, HIV-positive Ugandans were unable to mount S. mansoni specific immunological responses, which may partly explain their increased susceptibility to reinfection [58] .
Human T cell leukemia virus type-I (HTLV1) infection also appears to make the host more susceptible to schistosomal infection. HTLV1 coinfected patients in Brazil had lower levels of liver fibrosis than controls but the efficacy of praziquantel was lower [59 ,60] . Studies continue to assess traditional remedies as alternatives to praziquantel, such as extracts of myrrh [61] and a traditional Sudanese remedy Balanites aegyptiaca [62] , with promising results in mice.
Nematodes
This is a fascinating area of significant new concepts over the last few years.
Immunological interactions
There has been much debate about the effect of HIV on intestinal parasite infection and vice versa. Hypotheses suggesting both a protective and detrimental effect of intestinal parasite infections on susceptibility to HIV and disease have been proposed, but current conflicting immunological and clinical data provide a mixed picture.
Brooker et al. [63 ] have published a comprehensive review that examines the detailed immunology, biology, epidemiology and global disease burden of hookworm infection. Their review of immune modulation and coinfection with other pathogens is particularly useful. It has been speculated that infection with helminths is detrimental and leads to increased susceptibility to infections such as tuberculosis and HIV. This is largely due to the observed increase in type 2 (Th2) cytokine response and suppression of type 1 (Th1) immune response. It has been suggested that chronic activation of the immune system by helminths producing large volumes of antigenic material makes individuals more prone to HIV infection and, once infected, to higher viral loads and more rapid progression [64 ] . The enhanced Th2 immune response should lead to hyporesponsiveness and anergy, affecting the host response to immunization. Few data have been published in support of these hypotheses, however.
Increased understanding of the immune response to gastrointestinal nematodes may explain why some individuals are more susceptible to reinfection than others. BCG has been shown to have a protective effect against intestinal nematode infection in African HIV-positive children, particularly against Strongyloides spp. [65] . The authors propose that BCG promotes a Th1 response and that this reduces susceptibility to helminth infections. An earlier study in Malawi [66] , however, found no association between helminth infections and BCG.
In a Cameroonian population, whole blood cytokine levels were measured before and after deworming. Levels of interleukins, IL-5, IL-13, IL-10, IL-12, tumour necrosis factor a and INF-g were measured. Individuals susceptible to reinfection had a weaker type Th2 response, with a particularly strong negative association with IL-5 and IL-13 [67] . This confirms earlier reports that explained the decrease in worm load after the age of 11, with an increase in Th2-associated cytokine levels [68] . Reports from Malawi suggest that intestinal helminths are unlikely to be an increased risk factor for the development of nontyphoidal salmonella infection in HIV-positive adults [69] .
Further work is needed to improve our understanding of the interactions between host and parasite and the interaction with other infections and diseases. The work described later in Crohn's disease suggests an evolutionary benefit to being host to helminth infections!
Strongyloidiasis
The nematode Strongyloides stercoralis has a highly advanced life cycle from a survival viewpoint. In particular, the external cycle in the soil can be bypassed by the process of 'autoinfection'. Here, larvae normally excreted in the stool may penetrate the rectal mucosa or perianal skin to continue a reproductive life cycle in the host, without the need for an external environment [70 ] . Strongyloidiasis as a clinical disease can therefore continue indefinitely, even when the host permanently leaves an endemic area. Patients with such chronic autoinfective Strongyloides infections are more likely to have the classical larva currens ('creeping eruption') rash of larval migration rather than the gastrointestinal symptoms (diarrhoea and sometimes abdominal pain) seen more commonly in acute infections [70 ,71 ] . In both forms of infection, however, there may be no symptoms at all, but significant blood eosinophilia is very common [71 ,72] .
Immunosuppression in patients with untreated strongyloidiasis (usually the chronic form) may lead to massive larval migration from the gut into the peritoneum, liver, lungs and even the central nervous system. Peritonitis and Gram-negative septicaemia can occur, and the outcome is often fatal. This syndrome, known as 'hyperinfection' [73 ,74 ] , is the most important complication of strongyloidiasis. Intercurrent steroid treatment is the most common cause of hyperinfection, and a recent case report reminds us of the historically well recognized association with lepromatous leprosy and its immune defects which have similarities with those found in AIDS [75] . Many other factors leading to transient immune suppression have been implicated -for example, other immunosuppressive drugs, malnutrition, malignancies, radiotherapy and diabetic ketoacidosis [73 ,74 ,76] , and alcohol abuse [12] . Sometimes partial dissemination (usually to the lungs) or 'pseudo-hyperinfection' may occur [76, 77] . The treatment of disseminated and hyperinfective strongyloidiasis is difficult, but parenteral ivermectin is probably the drug of choice [78] .
A longstanding paradox has been why disseminated strongyloidiasis, or indeed Strongyloides infection in general, is not seen more frequently in patients with HIV infection living in endemic areas [70 ] . Evidence for an increased prevalence of strongyloidiasis in HIV-infected patients is either lacking, anecdotal, or inconclusive [14,70 ,79] . A recent report may explain the lack of association between disseminated strongyloidiasis and HIV infection [80 ] . Dissemination requires the direct development of infective larvae in the gut, but there is evidence that as CD4 counts fall in late-stage HIV, this process declines in favour of indirect development (which does not favour dissemination). Although this observation requires confirmation, it may well explain the problematic relationship between strongyloidiasis and HIV infection. Conversely, improved immune responses induced by prescription of HAART may lead to apparent symptoms of hyperinfection that are really due to HIV immune reconstitution syndrome [81 ,82 ] .
The associations of HTLV1 infection and Strongyloides, especially hyperinfection, have been recognized for many years [83] , and may relate to decreased serum IgE levels in HTLV1 carriers [84] . In a case control study of female blood donors in Guadeloupe, the strongest risk factor for HTLV1 seropositivity was the concurrent presence of antibodies to S. stercoralis (odds ratio (OR) 3.6), followed by low socioeconomic status or educational level (OR 2, for either) or agricultural activities (OR 2.8) [85] .
In the Dominican Republic, the prevalence of HTLV1 antibodies in the blood donor population is 2.7%, but 71% of recent cases of Strongyloides hyperinfection have been seropositive for HTLV1 [86] .
Diagnosis by stool microscopy is notoriously difficult [7] , but modern serological tests (in particular, enzymelinked immunosorbent assay (ELISA)) are sensitive and specific [72] . There is now a strong humanitarian and economic case for screening at-risk groups for strongyloidiasis, and for treating those who are ELISA positive, with a view to preventing the risk of future disseminated disease [87 ] . At-risk groups include veterans from the Second World War in Southeast Asia and the Far East [71 ] as well as those residing in or originating from endemic areas who need or might need immunosuppressive drugs in the future (e.g. patients with asthma, potential organ transplant patients etc.) [88] .
Strongyloides stercoralis infections were previously treated with tiabendazole, which was relatively toxic and only moderately effective. Modern treatment with albendazole or ivermectin is much safer and more effective [70 ,71 ] , but patients need prolonged follow up to confirm eradication of parasites [89] . In patients coinfected with HTLV1 and Strongyloides, a higher dose of ivermectin has been proposed. In Japan, where 38% of patients are coinfected, the treatment failure rate is approximately 50% with standard doses of ivermectin of 110 mg/kg. At a dose of 200 mg/kg, the long-term helminth cure rate was 90% (18/20) [90] .
Inflammatory bowel disease and helminths
Induction of Th2 cytokine responses and nonspecific downregulation of Th1 responses occur in helminth infections, whereas in inflammatory bowel disease such as Crohn's and ulcerative colitis, there is thought to be a failure to downregulate Th1 inflammatory responses. This development may explain the symbiotic relationship humans have with intestinal parasites, and the relatively low incidence of inflammatory bowel disease (IBD) in under-developed countries compared with the higher incidence in more developed countries, where there is a lower exposure to intestinal parasites.
It seems bizarre to think that organisms which have evolved to evade our host immune defences may be beneficial in the treatment of IBD. Trichuris suis, the porcine whipworm, is genetically similar to the human whipworm T. trichiura. Unlike the human pathogen, T. suis usually causes only transient infection in humans without causing invasive disease. Oral treatment with live ova of T. suis has been successfully used to reduce symptoms of IBD [91] , with symptom reduction confirmed in a subsequent randomized, double-blind trial in 54 patients with ulcerative colitis [92 ] . Similar benefit was seen in patients with Crohn's disease [93] .
The use of parasites as a potential therapy for IBD should be viewed with caution, as we do not fully understand their effects on the immune system in immunocompetent hosts, let alone the immunocompromised host. T. suis is thought to be safe, but is still a potentially invasive parasite, with the risk that it might migrate from the intestine, even of a human host, to cause other pathology [94] .
Conclusion
Interactions of parasites with their human hosts produce more complex immunological effects than have previously been appreciated. More clinical data are required to support or refute new hypotheses about these interactions, and to justify novel therapeutic approaches. Meanwhile, cheap and accessible diagnostic tests and treatments are still needed in the tropics, where the majority of immunosuppressed people with parasitic infections reside.
